# Clinical experience with the addition of pramlintide in patients with insulin-requiring type 2 diabetes.

> PubMed lists PMID 17909093 in Diabetes care as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2007-10-01 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-17909093-pramlintide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-28
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-17909093-pramlintide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-17909093-pramlintide-v1.json
- Content SHA-256: `da8f030dabf9501551f1860a01c8aad5082f69f1e877b18f78402d1a5e54a40c`

## Claims and source pins

### Headline

Clinical experience with the addition of pramlintide in patients with insulin-requiring type 2 diabetes. ([`pubmed-observation-pmid-17909093-2026-01-28-a87fc8d4c0ba`](#source-pubmed-observation-pmid-17909093-2026-01-28-a87fc8d4c0ba))

### Summary

PubMed lists PMID 17909093 in Diabetes care as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2007-10-01 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-17909093-2026-01-28-a87fc8d4c0ba`](#source-pubmed-observation-pmid-17909093-2026-01-28-a87fc8d4c0ba))

### Paragraph 1

PubMed lists PMID 17909093 in Diabetes care as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2007-10-01 (day precision). PeptideScanner associated the retained record with the identity slug pramlintide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-17909093-2026-01-28-a87fc8d4c0ba`](#source-pubmed-observation-pmid-17909093-2026-01-28-a87fc8d4c0ba))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-17909093-2026-01-28-a87fc8d4c0ba`](#source-pubmed-observation-pmid-17909093-2026-01-28-a87fc8d4c0ba))

## Sources

<a id="source-pubmed-observation-pmid-17909093-2026-01-28-a87fc8d4c0ba"></a>
- **Clinical experience with the addition of pramlintide in patients with insulin-requiring type 2 diabetes. · retained source version 1:2026-01-28:current:a87fc8d4c0baa9b4f8f784f8200f53c3f7c4fc347addd2fcd5580620d09afaed** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/17909093/) (`pubmed-observation-pmid-17909093-2026-01-28-a87fc8d4c0ba`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Clinical experience with the addition of pramlintide in patients with insulin-requiring type 2 diabetes." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-17909093-pramlintide-v1.json SHA-256: da8f030dabf9501551f1860a01c8aad5082f69f1e877b18f78402d1a5e54a40c.